ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies.
In a highly fragmented industry, we are one of a small group of organisations with the capability and expertise to conduct clinical trials and development projects on either a local or global basis.
We have the operational flexibility to provide development services on a stand-alone basis or as part of an integrated “full service” solution. We are also an 'end-to-end' Pharmacovigilance service provider and this includes Post Marketing Surveillance activities too.
Specialties
CRO, Contract Research Organisation, Clinical Research, Drug Development, Central Laboratory, Imaging Laboratory, Late Phase Research, Early Phase Drug Discovery
New hires at ICON plc
-
Came from...
CISTIB - Center for Computational Imaging and Simulation Technologies, Chief Operations Officer
-
-
Came from...
Advanced Practice Strategies (APS), Sr. Director of Patient Safety Initiatives
-
ICON plc Activity on LinkedIn
-
-
-
-
ICON plc has a new Clinical Trial Manager
Nalja Grissom, MBA is now Clinical Trial Manager
-
ICON plc has a new Sr. Director, Business Development
Carter Vincent is now Sr. Director, Business Development, was Sr. Director of Patient Safety Initiatives at Advanced Practice Strategies (APS)
-
ICON plc has a new Business Process Analyst
Deb Robinson is now Business Process Analyst
-
ICON plc is hiring: Study Coordinator in Houston, TX
-
ICON plc has a new Document Management Assistant
Michael Penland is now Document Management Assistant
-
-
